Elutia, Inc. (ELUT)
0.8198
-0.01
(-1.23%)
USD |
NASDAQ |
Sep 25, 16:00
0.81
-0.01
(-1.20%)
After-Hours: 19:59
Elutia Profit Margin (Quarterly) : -315.0% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -315.0% |
| March 31, 2026 | -253.5% |
| December 31, 2025 | -199.0% |
| September 30, 2025 | -11.53% |
| June 30, 2025 | -258.1% |
| March 31, 2025 | -63.94% |
| December 31, 2024 | -254.1% |
| September 30, 2024 | 85.20% |
| June 30, 2024 | -450.8% |
| March 31, 2024 | -268.8% |
| December 31, 2023 | -259.1% |
| September 30, 2023 | -139.0% |
| June 30, 2023 | -121.7% |
| Date | Value |
|---|---|
| March 31, 2023 | -153.0% |
| December 31, 2022 | -91.25% |
| September 30, 2022 | -188.6% |
| June 30, 2022 | -74.36% |
| March 31, 2022 | -70.89% |
| December 31, 2021 | -83.45% |
| September 30, 2021 | -72.41% |
| June 30, 2021 | -19.61% |
| March 31, 2021 | -39.33% |
| December 31, 2020 | -42.96% |
| September 30, 2020 | -57.17% |
| June 30, 2020 | -60.36% |
| March 31, 2020 | -46.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -49.97% |
| Return on Invested Capital | -125.2% |
| Gross Profit Margin (Quarterly) | 59.62% |
| Operating Margin (Quarterly) | -243.1% |
| Return on Net Operating Assets | -172.1% |